王丽梅1 师长宏2 柏银兰1 张海2 康健1 张薇1 徐志凯1.结核杆菌Hsp65 与人IL-2 融合蛋白在耻垢杆菌表达[J].现代生物医学进展英文版,2011,11(18):3405-3407. |
结核杆菌Hsp65 与人IL-2 融合蛋白在耻垢杆菌表达 |
Expression of Heat Shock Protein 65 of Mycobacterium Tuberculosis andHuman IL-2 Fused Gene in Mycobacterium Smegmatis |
|
DOI: |
中文关键词: 结核分枝杆菌 HSP65 IL-2 耻垢分枝杆菌 |
英文关键词: Mycobacterium tuberculosis HSP65 IL-2 Mycobacterium Smegmatis |
基金项目:国家自然科学基金项目(No. 30801055);" 十一五" 传染病重大专项项目(No. 2008ZX10003-013) |
|
Hits: 1046 |
Download times: 1031 |
中文摘要: |
目的:构建能够分泌表达结核分枝杆菌热休克蛋白65(Hsp65)与人IL-2 融合蛋白的重组耻垢分枝杆菌(recombinant
Mycobacterium Smegmatis, rMs)。方法:用EcoRⅤ和Hind Ⅲ双酶切含Hsp65-IL-2 融合基因的pPRO-hsp65-IL-2 载体,回收目的基
因片断Hsp65-IL-2,并将其亚克隆入同样双酶切的大肠埃希菌- 分枝杆菌穿梭分泌表达载体pDE22 中。重组质粒
pDE22-hsp65-IL-2 酶切鉴定正确后,电穿孔转化MS 感受态,潮霉素抗性压力筛选阳性rMs。Western-blot 鉴定rMs 培养上清蛋白
中目的蛋白的表达。结果:重组pDE22-hsp65-IL-2 质粒酶切后可获得约2000 bp 片段,与预期大小一致。Western-blot 结果表明,
rMs 培养上清蛋白中有特异性反应条带,大小为78kD,与Hsp65-IL-2 融合蛋白大小相一致。结论:成功构建了大肠埃希菌- 分枝
杆菌穿梭分泌表达载体pDE22-hsp65-IL-2,为该rMs 的免疫学特性及抗结核分枝杆菌感染的保护效果研究奠定了基础。 |
英文摘要: |
Objective: To construct the recombinant Mycobacterium Smegmatis which can express the fused protein of the heat
shock protein 65 of Mycobacterium tuberculosis with human IL-2. Methods: The EcoRⅤ/HindⅢ fragment of the fused gene Hsp65-IL-2
digested from the plasmid pPRO-hsp65-IL-2 was subcloned into the E.coli-Mycobacterium shuttle vector pDE22 predigested by the same
restrictive endoenzymes. The positive pDE22-hsp65-IL-2 recombinant plasmid was identified by restriction enzymatic digestion and
then transformed into Ms cells by electroporation. The expression of the fusion protein Hsp65-IL-2 in the culture of recombinant Ms(rMs)
was detected byWestern-blot. Results: A 2000bp fragment was obtained from the shuttle vector pDE22-hsp65-IL-2 by restriction enzyme
digestion, which was identical with the predicted. The Western-blot showed that there was a specific reactive band at the size of 78kD in
the culture filtrate proteins of rMs, which was identical with the size of Hsp65-IL-2 fusion protein. Conclusion: The shuttle expression
vector pDE22-hsp65-IL-2 was constructed successfully, which provided the foundation for the study of the immunogenicity and protective
efficacy of rMs against MTB infection. |
View Full Text
View/Add Comment Download reader |
Close |